Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-28

FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)

View source ↗

Summary

FDA approves a supplemental application for Ledipasvir and Sofosbuvir by Asegua Therapeutics LLC. The change pertains to the Ledipasvir and Sofosbuvir product u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ledipasvir and Sofosbuvir (Ledipasvir and Sofosbuvir)

Snippet

SUPPL AP for LEDIPASVIR AND SOFOSBUVIR (LEDIPASVIR AND SOFOSBUVIR)